Atlas Trials

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Clinical trial NCT02856568 · WITHDRAWN

Trial details

NCT number
NCT02856568
Sponsor
Mayo Clinic
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Resectable CholangiocarcinomaRecurrent CholangiocarcinomaStage III Extrahepatic Bile Duct CancerStage III Intrahepatic CholangiocarcinomaStage IIIA Hilar CholangiocarcinomaStage IIIB Hilar CholangiocarcinomaStage IVA Extrahepatic Bile Duct CancerStage IVA Hilar CholangiocarcinomaStage IVA Intrahepatic CholangiocarcinomaStage IVB Extrahepatic Bile Duct CancerStage IVB Hilar CholangiocarcinomaStage IVB Intrahepatic Cholangiocarcinoma
Start date
2017-05-01
Primary completion
2021-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.